Opposing effects of omega-3 and omega-6 long chain polyunsaturated Fatty acids on the expression of lipogenic genes in omental and retroperitoneal adipose depots in the rat.
This study aimed to determine the effect of varying dietary intake of the major n-3 PUFA in human diets, alpha-linolenic acid (ALA; 18 : 3n-3), on expression of lipogenic genes in adipose tissue. Rats were fed diets containing from 0.095%en to 6.3%en ALA and a constant n-6 PUFA level for 3 weeks. Samples from distinct adipose depots (omental and retroperitoneal) were collected and mRNA expression of the pro-lipogenic transcription factors Sterol-Retinoid-Element-Binding-Protein1c (SREBP1c) and Peroxisome Proliferator Activated Receptor-gamma (PPARgamma), lipogenic enzymes Sterol-coenzyme Desaturase1 (SCD-1), Fatty Acid Synthase (FAS), lipoprotein lipase (LPL) and glycerol-3-phosphate dehydrogenase (G3PDH) and adipokines leptin and adiponectin determined by qRT-PCR. Increasing dietary ALA content resulted in altered expression of SREBP1c, FAS and G3PDH mRNA in both adipose depots. SREBP1c mRNA expression was related directly to n-6 PUFA concentrations (omental, r(2) = .71; P < .001; Retroperitoneal, r(2) = .20; P < .002), and inversely to n-3 PUFA concentrations (omental, r(2) = .59; P < .001; Retroperitoneal, r(2) = .19; P < .005) independent of diet. The relationship between total n-6 PUFA and SREBP1c mRNA expression persisted when the effects of n-3 PUFA were controlled for. Altering red blood cell concentrations of n-3 PUFA is thus associated with altered expression of lipogenic genes in a depot-specific manner and this effect is modulated by prevailing n-6 PUFA concentrations.
Muhlhausler
B S
BS
FOODplus Research Centre, School of Agriculture, Food and Wine, The University of Adelaide, Adelaide 5064, Australia.
Cook-Johnson
R
R
James
M
M
Miljkovic
D
D
Duthoit
E
E
Gibson
R
R
Best Pract Res Clin Endocrinol Metab. 2005 Dec;19(4):589-603
16311219
Can J Biochem Physiol. 1959 Aug;37(8):911-7
13671378
Int J Obes. 1991 Sep;15 Suppl 2:67-81
1794941
J Lipid Res. 2002 Sep;43(9):1537-43
12235186
Am J Clin Nutr. 2006 Feb;83(2):461S-465S
16470013
Am J Clin Nutr. 1994 Jun;59(6):1304-9
7910999
Trends Endocrinol Metab. 2000 Oct;11(8):327-32
10996528
Endocr Rev. 2005 May;26(3):439-51
15897298
Proc Nutr Soc. 2002 May;61(2):299-309
12133213
Vasc Health Risk Manag. 2008;4(2):297-304
18561505
Endocr Rev. 2000 Dec;21(6):697-738
11133069
Am J Clin Nutr. 2006 Jun;83(6 Suppl):1483S-1493S
16841858
Diabetes Care. 1991 Dec;14(12):1132-43
1773700
Am J Clin Nutr. 2007 May;85(5):1267-74
17490962
EMBO Rep. 2001 Apr;2(4):282-6
11306547
J Lipid Res. 2003 Feb;44(2):271-9
12576509
Prog Lipid Res. 2006 May;45(3):203-36
16516300
Biochim Biophys Acta. 2005 May 30;1740(2):266-86
15949694
Lipids. 2004 Dec;39(12):1177-85
15736913
Obes Rev. 2005 Feb;6(1):5-7
15655032
Lipids. 2003 Apr;38(4):391-8
12848284
Nestle Nutr Workshop Ser Pediatr Program. 2006;57:235-42; discussion 243-5
16632969
Lipids. 1990 Sep;25(9):505-16
2250586